InvestorsHub Logo
Followers 275
Posts 32727
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Tuesday, 03/18/2014 4:48:50 PM

Tuesday, March 18, 2014 4:48:50 PM

Post# of 704244
Ou, I think I know how to help.


Let's pretend the pseudo progression group reached their minimal event number.

1. If the primary group reached statistical significance, but the pseudo progression group did not, then NWBO only goes forward with the primary data for FDA approval.

2. If the primary group reached statistical significance and so did the Pseudoprogression group, then NWBO goes forward with combined data for approval.


The goal is to get DCVAX-L approved for the correct types of patients it can help.

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News